Transcranial magnetic stimulation: Neurophysiological and clinical applications.

Clinical applications Frontal lobes Neurophysiology Noninvasive brain stimulation Transcranial magnetic stimulation Virtual lesion

Journal

Handbook of clinical neurology
ISSN: 0072-9752
Titre abrégé: Handb Clin Neurol
Pays: Netherlands
ID NLM: 0166161

Informations de publication

Date de publication:
2019
Historique:
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 27 2 2020
Statut: ppublish

Résumé

Transcranial magnetic stimulation (TMS) is a safe and noninvasive means of electrically stimulating the brain by electromagnetic induction. TMS is capable of probing intracortical circuits and modulating cortical activity in humans; as such it has been instrumental to studying the neurophysiology and functional neuroanatomy of the frontal lobes. For example, using TMS to induce "virtual lesions"-transient disruption of function in the targeted brain region-has yielded important insights into the functional organization of the prefrontal cortex (PFC) with respect to working memory, language, and other core cognitive functions. Whereas neuroimaging is typically limited to observing correlations between brain function and behavior, TMS, by interacting with neural circuits, can lead to causal inferences that bridge human, nonhuman primate, and other model system studies. Applied repetitively in trains of stimuli, TMS is also capable of normalizing aberrant patterns of cortical activity in the treatment of neurologic and psychiatric disorders. The earliest and most well-established clinical use of repetitive TMS is in the treatment of medication-resistant depression with high-frequency stimulation of the left dorsolateral PFC. Research efforts to identify other promising clinical applications-such as for stroke and Alzheimer's disease-are rapidly expanding; however, the majority of these indications have yet to have devices cleared by the FDA for on-label use.

Identifiants

pubmed: 31590749
pii: B978-0-12-804281-6.00005-7
doi: 10.1016/B978-0-12-804281-6.00005-7
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-92

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Matthew J Burke (MJ)

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Peter J Fried (PJ)

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Alvaro Pascual-Leone (A)

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Guttmann Brain Health Institute, Institut Guttmann de Neurorehabilitacio, Universitat Autonoma de Barcelona, Barcelona, Spain; Marcus Institute for Aging Research, Hebrew Senior Life, Harvard Medical School, Boston, MA, United States. Electronic address: apleone@bidmc.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH